Wegovy (semaglutide) does not significantly affect cytochrome P450 enzymes, so clinically relevant pharmacokinetic interactions with common anti-seizure medications are not expected
GLP-1RAs show promise in treating autoimmune diseases Evidence of therapeutic potential of GLP-1RAs in autoimmune and autoinflammatory diseases, including psoriasis, inflammatory bowel diseases, rheumatoid arthritis, asthma, multiple sclerosis, Sjgrens syndrome, and systemic lupus erythematosus
Injections require a small needle stick once weekly or every two weeks, but they deliver reliable, dose-dependent results backed by years of trial data and real-world outcomes
Thank you for listening and remember were here to support you on your weight loss Journey
Do not administer an extra dose or increase the dose to make up for the missed dose